Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Mar 29:5:18011.
doi: 10.1038/hgv.2018.11. eCollection 2018.

Refining the clinical phenotype of Okur-Chung neurodevelopmental syndrome

Moe Akahira-Azuma  1 , Yoshinori Tsurusaki  2 , Yumi Enomoto  2 , Jun Mitsui  3 , Kenji Kurosawa  1
Affiliations

Refining the clinical phenotype of Okur-Chung neurodevelopmental syndrome

Moe Akahira-Azuma et al. Hum Genome Var. .

Abstract

We describe an 8-year-old Japanese boy with a de novo recurrent missense mutation in CSNK2A1, c.593A>G, that is causative of Okur-Chung neurodevelopmental syndrome. He exhibited distinctive facial features, severe growth retardation with relative macrocephaly, and friendly, hyperactive behavior. His dysmorphic features might suggest a congenital histone modification defect syndrome, such as Kleefstra, Coffin-Siris, or Rubinstein-Taybi syndromes, which are indicative of functional interactions between the casein kinase II, alpha 1 gene and histone modification factors.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
The proband and cranial magnetic resonance imaging (MRI). The patient at 3 years and 7 months (a) and 7 years and 10 months of age (b), revealing synophrys, hypertrichosis, down-slanting palpebral fissures, and a bulbous nose. Axial T2-weighted view (c) and saggital T1-weighted view (d) of cranial MRI revealing a reduced anterior pituitary gland and delayed myelination.
Figure 2
Figure 2
CSNK2A1 mutation. (a) Electropherogram of the patient and his parents. (b) The mutation occurred at an amino acid residue that is evolutionarily conserved in nine different species. The altered nucleotide is highlighted in the gray box. (c) De novo mutation (c.593A>G, p.K198R) identified in the patient. The CSNK2A1 protein contains four domains: the ATP/GTP binding loop, basic cluster, active site, and activation segment.
See this image and copyright information in PMC

References

    1. Okur V, Cho MT, Henderson L, Retterer K, Schneider M, Sattler S et al. De novo mutations in CSNK2A1 are associated with neurodevelopmental abnormalities and dysmorphic features. Hum Genet 2016; 135: 699–705. - PubMed
    1. Deciphering Developmental Disorders Study. Prevalence and architecture of de novo mutations in developmental disorders. Nature 2017; 542: 433–438. - PMC - PubMed
    1. Trinh J, Hüning I, Budler N, Hingst V, Lohmann K, Gillessen-Kaesbach G. A novel de novo mutation in CSNK2A1: reinforcing the link to neurodevelopmental abnormalities and dysmorphic features. J Hum Genet 2017; 62: 1005–1006. - PubMed
    1. Benveniste EN, Gray GK, McFarland BC. Protein kinase CK2 and dysregulated oncogenic inflammatory signaling pathways. In: Ahmed K, Issinger OG, Szyszka R (eds). Protein Kinase CK2 Cellular Function in Normal and Disease States, vol 12. Springer: Switzerland, 2015, e-book.
    1. Ceglia I, Flajolet M, Rebholz H. Predominance of CK2alpha over CK2alpha′ in the mammalian brain. Mol Cell Biochem 2011; 356: 169–175. - PubMed

Data Citations

    1. Kurosawa Kenji.HGV Database. 2018. 10.6084/m9.figshare.hgv.1917. - DOI

LinkOut - more resources